These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19564434)

  • 1. Evaluating the capability and cost of a mass influenza and pneumococcal vaccination clinic via computer simulation.
    Washington ML
    Med Decis Making; 2009; 29(4):414-23. PubMed ID: 19564434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The number needed to vaccinate (NNV) and population extensions of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over.
    Kelly H; Attia J; Andrews R; Heller RF
    Vaccine; 2004 Jun; 22(17-18):2192-8. PubMed ID: 15149776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Splenectomy and pneumococcal vaccination].
    Postma MJ; Heijnen MA; de Vries R; Beutels P; Jager JC
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1141-2; author reply 1142. PubMed ID: 12822527
    [No Abstract]   [Full Text] [Related]  

  • 4. Missed opportunities for pneumococcal and influenza vaccination of Medicare pneumonia inpatients--12 western states, 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Oct; 46(39):919-23. PubMed ID: 9347905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of influenza and pneumococcal vaccinations among elderly people in Japan.
    Cai L; Uchiyama H; Yanagisawa S; Kamae I
    Kobe J Med Sci; 2006; 52(3-4):97-109. PubMed ID: 16855372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization season: for more than just flu.
    Gold JA
    WMJ; 2006 Oct; 105(7):57, 54. PubMed ID: 17163091
    [No Abstract]   [Full Text] [Related]  

  • 7. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.
    De Wals P; Black S; Borrow R; Pearce D
    Clin Ther; 2009 Oct; 31(10):2152-69. PubMed ID: 19922887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
    Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1007-12. PubMed ID: 15525897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza and pneumococcal vaccination in older veterans: results from the behavioral risk factor surveillance system.
    Chi RC; Reiber GE; Neuzil KM
    J Am Geriatr Soc; 2006 Feb; 54(2):217-23. PubMed ID: 16460371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical practice and public policy for influenza and pneumococcal vaccination of the elderly.
    Fedson DS
    Clin Geriatr Med; 1992 Feb; 8(1):183-99. PubMed ID: 1576575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combating influenza and pneumococcal disease: the public health system needs some magic.
    Hendrickson S; Ransom J
    J Public Health Manag Pract; 2007; 13(6):672-4. PubMed ID: 17984725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
    Melegaro A; Edmunds WJ
    Vaccine; 2004 Oct; 22(31-32):4203-14. PubMed ID: 15474710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacoeconomics of vaccinations in chronic obstructive pulmonary disease].
    Słominski JM; Kubiak A
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():83-5. PubMed ID: 15524025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-wide benefits of routine vaccination of children against influenza.
    Weycker D; Edelsberg J; Halloran ME; Longini IM; Nizam A; Ciuryla V; Oster G
    Vaccine; 2005 Jan; 23(10):1284-93. PubMed ID: 15652671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza and pneumococcal vaccination levels among persons aged > or = 65 years--United States, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Jun; 50(25):532-7. PubMed ID: 11446571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifesaving opportunities missed: the challenge of vaccinating older Americans for pneumococcal diseases and influenza.
    Tschantz K; Foley LA
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2000 Oct; (IB45):1-9. PubMed ID: 11885591
    [No Abstract]   [Full Text] [Related]  

  • 19. Influenza and pneumococcal vaccination coverage levels among persons aged > or = 65 years--United States, 1973-1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Jul; 44(27):506-7, 513-5. PubMed ID: 7596336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza and pneumococcal immunization rates among a high-risk population.
    Chan-Tack KM
    South Med J; 2001 Mar; 94(3):323-4. PubMed ID: 11284519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.